442
Participants
Start Date
September 30, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg
Seretide Diskus (salmeterol/fluticasone) 50/500 μg
Research Site, Monte Grande
Research Site, Quilmes
Research Site, San Miguel de Tucumán
Research Site, Ciudad Autonoma de Bs. As.
Research Site, Ciudad de Buenos Aires
Research Site, Concord
Research Site, Adelaide
Research Site, Daw Park
Research Site, Woodville South
Research Site, Melbourne
Research Site, Parkville
Research Site, Nedlands
Research Site, Jambes
Research Site, Malmedy
Research Site, Montigny-le-Tilleul
Research Site, Porto Alegre
Research Site, Juiz de Fora
Research Site, Recife
Research Site, Rio de Janeiro
Research Site, Porto Alegre
Research Site, Florianópolis
Research Site, Santo André
Research Site, São Paulo
Research Site, Rio de Janeiro
Research Site, Aalborg
Research Site, Hellerup
Research Site, Hvidovre
Research Site, København NV
Research Site, Odense C
Research Site, Rødovre Municipality
Research Site, Silkeborg
Research Site, Berlin
Research Site, Erfurt
Research Site, Leipzig
Research Site, Marburg
Research Site, Hyderabad
Research Site, Bangalore
Research Site, Jaipur
Research Site, Coimbatore
Research Site, Noida
Research Site, Manila
Research Site, Quezon City
Research Site, Dartford
Research Site, Hamilton
Research Site, Motherwell
Research Site, Cookstown
Research Site, Limavady
Research Site, Newtownabbey
Research Site, Barry
Research Site, Barry
Research Site, Bradford-on-Avon
Research Site, Airdrie
Research Site, Birmingham
Research Site, Blantyre
Research Site, Bolton
Research Site, Carrickfergus
Research Site, Chesterfield
Research Site, Coventry
Research Site, Hamilton
Lead Sponsor
AstraZeneca
INDUSTRY